Reports and Statements

  • Human Papillomavirus and Related Diseases in Canada. Summary Report 2015-03-20: Read Document (English)
  • La vaccination contre les VPH au Québec: mise à jour des connaissances et propositions du comité d’experts. Read Document (French)
  • An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†. Read Document (English)

 

Books / Articles

Books About Cancer
  • Healer of Cancer: The Power of the Mind, by Dr. Christian Boukaram: External Link

Books About HPV
  • The HPV Vaccine Controversy, by Shobha S. Krishnan, M.D. External Link

Articles
  • Including males in Canadian human papillomavirus vaccination programs: a policy analysis.Read Document (English)

  • Rebuttal: Do you approve of spending $300 million on HPV Vaccination?- Dr Marc Steben says yes.Read Document (English)

  • Beliefs, behaviours and HPV vaccine: Correcting the myths and the misinformation Read Document (English)

  • The Early Benefits of Human Papillomavirus Vaccination on Cervical Dysplasia and Anogenital Warts Read Document (English)

  • Adverse events following immunization in Ontario's female school-based HPV program Read Document (English)

  • Quadrivalent human papillomavirus vaccination in girls and the risk of autoimmune disorders: the Ontario Grade 8 HPV Vaccine Cohort Study Read Document (English)

  • Are twenty human papillomavirus types causing cervical cancer? Read Document (English)

  • Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes Read Document (English) 

  • Sex Differences Among College Students in Awareness of the HPV Vaccine and Vaccine Options Read Document (English)

  • HPV vaccination: for women of all ages? Read Document (English) 

  • What is the responsibility of national government with respect to vaccination? Read Document (English) 

  • Financial Incentives for Increasing Uptake of HPV Vaccinations: A Randomized Controlled Trial Read Document (English) 

  • Oral Human Paillomavirus (HPV) Infection among Unvaccinated High-Risk Young Adults Read Document (English)  

  • Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study Read Document (English)  

  • Indications for the HPV vaccine in adolescents: A review of the literature Read Document (English)  

  • The age of distribution of type-specific high-risk human papillomavirus incidence in two population-based screening trials Read Document (English)  

  • The Politics of HPV VAccination Advocacy: Effects of Source Expertise on Effectiveness of a Pro-Vaccine Message Read Document (English) 

  • Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study Read Document (English)  

  • Estimation of Geographic Variation in Human Papillomavirus Vaccine Uptake in Men and Women: An Online Survey Using Facebook Recruitment Read Document (English) 
  • Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: A transmission-dynamic modelling study Read Document (English) 
  • Human Papillomavirus Vaccine Knowledge and Attitudes, Preventative Health Behaviors, and Medical Mistrust Among a Racially and Ethnically Diverse Sample of College Women Read Document (English) 
  • Implementation Science in Cancer Prevention and Control: A framework for research and programs in low and middle-income countries Read Document (English) 
  • Beta-Test Results for an HPV Information Web Site: GoHealthyGirls.org- Increasing HPV Vaccine Uptake in the United States Read Document (English) 
  • Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescent and young adults Read Document (English) 
  • Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study Read Document (English) 
  • Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers Read Document (English) 
  • Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer Read Document (English) 

 

 

Information on HPV testing

  

Information on HPV vaccination

Gardasil®

English version of the Product Monograph
  • Product Monograph, Gardasil® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] Suspension for injection, Active Immunizing Agent: Read Document (English)
English version of the Consumer Information
  • Part III: Consumer Information, Gardasil® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine]: Read Document (English)
Version Française de la monographie de produit
  • Monographie de produit, Gardasil® [Vaccin recombinant quadrivalent contre le virus du papillome humain (types 6, 11, 16 et 18)] Suspension injectable, Agent pour une immunisation active: Read Document (French)
Version Française des renseignements pour le consommateur
  • Partie III: Renseignements pour le consommateur, Gardasil® [Vaccin recombinant quadrivalent contre le virus du papillome humain (types 6, 11, 16 et 18)]: Read Document (French)

 

Gardasil® 9

English version of the Product Monograph
  • Product Monograph, Gardasil® 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Suspension for injection, Active Immunizing Agent: Read Document (English)
English version of the Consumer Information
  • Part III: Consumer Information, Gardasil® 9 [Human Papillomavirus 9-valent Vaccine, Recombinant]: Read Document (English)
Version Française de la monographie de produit
  • Monographie de produit, Gardasil® 9 [Vaccin recombinant nonvalent contre le virus du papillome humain] Suspension injectable, Agent pour une immunisation active: Read Document (French)
Version Française des renseignements pour le consommateur
  • Partie III: Renseignements pour le consommateur, Gardasil® 9 [Vaccin recombinant nonavalent contre le virus du papillome humain]: Read Document (French)

 

Cervarix®

Health Canada Documents
English version of the Product Monograph
  • Product Monograph, Cervarix®[Human Papillomavirus vaccine Types 16 and 18 (Recombinant, AS04 adjuvanted)] Suspension for injection, Active Immunizing Agent. ATC code: J07BM02: Read Document (English)
Version Française de la monographie de produit
  • Monographie de produit, Gardasil® [Vaccin contre les types 16 et 18 du virus du papillome humain (recombinant, avec AS04 comme adjuvant)] Suspension injectable, Agent pour une immunisation active. Code ATC: J07BM02: Read Document (French)